As of 2025-06-16, the Intrinsic Value of Passage Bio Inc (PASG) is -5.11 USD. This PASG valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.39 USD, the upside of Passage Bio Inc is -1,405.74%.
Based on its market price of 0.39 USD and our intrinsic valuation, Passage Bio Inc (PASG) is overvalued by 1,405.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.11 - -5.11 | -5.11 | -1,405.74% |
| P/E | (17.40) - (24.49) | (21.72) | -5656.0% |
| DDM - Stable | (7.12) - (18.53) | (12.82) | -3379.5% |
| DDM - Multi | (0.54) - (1.10) | (0.72) | -285.0% |
| Market Cap (mil) | 24.30 |
| Beta | 1.35 |
| Outstanding shares (mil) | 62.15 |
| Enterprise Value (mil) | -39.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.50% |
| Cost of Debt | 5.00% |
| WACC | 7.59% |